Prevalence of sarcopenia in patients with rheumatoid arthritis using the revised EWGSOP2 and the FNIH definition.

Roswitha Dietzel Sabine WiegmannDiana BoruckiChristian DetzerKim Nikola ZeinerDésirée SchaumburgBjoern Bühring Frank Buttgereit Gabriele Armbrecht

Published in: RMD open (2022)

It was registered at the German Clinical Trials Registry (DRKS) as well as WHO Clinical Trials Registry (ICTRP) (DRKS00011873, registered on 16 March 2017).

Keyphrases

clinical trial
phase ii
risk factors
skeletal muscle
open label
phase iii
study protocol
double blind
randomized controlled trial